Ashira Lubkin
Infectious Diseases · 2016–2020
A researcher in the Science corpus: 4 papers; trusts 2 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Infectious Diseases — 50 citations into it
Whom Ashira Lubkin trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Papers from Ashira Lubkin's perspective
Ordered by how strongly the researchers Ashira Lubkin trusts endorse each paper. Same corpus, a different order for every researcher.
- Cryopyrin activates the inflammasome in response to toxins and ATP (Nature)
- Exploiting dominant‐negative toxins to combat Staphylococcus aureus pathogenesis
- Staphylococcal coagulase; mode of action and antigenicity.
- Staphylococcus aureus Leukocidin A/B (LukAB) Kills Human Monocytes via Host NLRP3 and ASC when Extracellular, but Not Intracellular
- Genetic requirements for Staphylococcus aureus abscess formation and persistence in host tissues
- Cytotoxic Virulence Predicts Mortality in Nosocomial Pneumonia Due to Methicillin-Resistant Staphylococcus aureus.
- Staphylococcus aureus Leukocidin LukED and HIV-1 gp120 Target Different Sequence Determinants on CCR5
- Nutritional immunity: transition metals at the pathogen-host interface (Nature Reviews Microbiology)
- Staphylococcus aureus leukocidins target endothelial DARC to cause lethality in mice
- Targeting leukocidin-mediated immune evasion protects mice from Staphylococcus aureus bacteremia
Their papers
- Exploiting dominant‐negative toxins to combat Staphylococcus aureus pathogenesis (2016) — 64 citations
- Identification of a domain critical for Staphylococcus aureus LukED receptor targeting and lysis of erythrocytes (2020) — 22 citations
- Staphylococcus aureus leukocidins target endothelial DARC to cause lethality in mice (2019) — 39 citations
- Identification of biologic agents to neutralize the bicomponent leukocidins of Staphylococcus aureus (2019) — 26 citations